Friday, March 06, 2015 4:59:59 PM
Recent NEO News
- NeoGenomics Reports First Quarter 2024 Results • Business Wire • 04/30/2024 11:30:00 AM
- NeoGenomics Announces Senior Leadership Promotions • Business Wire • 04/18/2024 11:05:00 AM
- NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024 • Business Wire • 04/09/2024 11:00:00 AM
- NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting • Business Wire • 03/27/2024 12:30:00 PM
- NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report • Business Wire • 03/20/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:26:13 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 10:33:35 PM
- NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference • Business Wire • 03/01/2024 12:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:29:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:28:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:28:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:27:59 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/26/2024 09:15:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:32:59 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/20/2024 09:23:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 09:06:34 PM
- NeoGenomics Reports Fourth Quarter and Full Year 2023 Results • Business Wire • 02/20/2024 09:05:00 PM
- Market Cautiousness Ahead of Retail Giants’ Earnings; Oil Prices Dip • IH Market News • 02/20/2024 10:37:35 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/15/2024 09:26:23 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 03:04:34 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/09/2024 08:17:09 PM
- NeoGenomics Signs Working with Cancer Pledge in Support of Employees • Business Wire • 02/01/2024 12:05:00 PM
- NeoGenomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20, 2024 • Business Wire • 01/30/2024 12:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 10:28:20 PM
- NeoGenomics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference • Business Wire • 01/02/2024 12:05:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM